| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| A2151 | TCI | 4-Amino-2-chloro-6,7-dimethoxyquinazoline | >98.0%(HPLC)(N) | 380元/5G; 1250元/25G; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(HPLC)(N) | | 分子式/分子量 | C10H10ClN3O2 = 239.66 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 747463 | | PubChem物质ID | 87560582 | | MDL编号 | MFCD00051734 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(with Total Nitrogen) | min. 98.0 % |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H315 : 造成皮肤刺激。 H319 : 造成严重眼刺激。
| | 防范说明 | P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/戴防护眼罩/戴防护面具。 P302 + P352 : 如皮肤沾染:用水充分清洗。 P337 + P313 : 如仍觉眼刺激:求医/就诊。 P305 + P351 + P338 : 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364 : 脱掉沾污的衣服,清洗后方可重新使用。 P332 + P313 : 如发生皮肤刺激:求医/就诊。
|
|
| 285025 | J&K | 4-Amino-2-chloro-6,7-dimethoxyquinazoline | 98% | 177元/5G; 548元/25G; 2095元/100G; | 咨询 |
基本信息 | 分子式 | C10H10ClN3O2 | | 分子量 | 239.66 | | 熔点 | 262-268 | | MDL编码 | MFCD00051734 | | Beilstein | 747463 | | EINECS 编号 | 245-821-7 |
安全信息 | 图形或危害标志 |  | | 提示语 | Warning | | 危险说明 | H315 H319 H335 | | 防范说明 | P281 P305+P351+P338 | | WGK | 3 | | TSCA | 否 |
|
| Y0000552 | | Doxazosin impurity F | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C10H10ClN3O2 | | 分子量 | 239.66 | | Beilstein | 747463 | | EC 号 | 245-821-7 | | MDL编号 | MFCD00051734 | | PubChem化学物质编号 | 329831015 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | mp | 262-268 ℃ (dec.) (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | COc1cc2nc(Cl)nc(N)c2cc1OC | | InChI | 1S/C10H10ClN3O2/c1-15-7-3-5-6(4-8(7)16-2)13-10(11)14-9(5)12/h3-4H,1-2H3,(H2,12,13,14) | | InChI key | HWIIAAVGRHKSOJ-UHFFFAOYSA-N |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P261 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0000622 | | Terazosin impurity A | European Pharmacopoeia (EP) Reference Standard | 1556.7元/10 mg; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C10H10ClN3O2 | | 分子量 | 239.66 | | Beilstein | 747463 | | MDL编号 | MFCD00051734 | | PubChem化学物质编号 | 329831057 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | mp | 262-268 ℃ (dec.) (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | COc1cc2nc(Cl)nc(N)c2cc1OC | | InChI | 1S/C10H10ClN3O2/c1-15-7-3-5-6(4-8(7)16-2)13-10(11)14-9(5)12/h3-4H,1-2H3,(H2,12,13,14) | | InChI key | HWIIAAVGRHKSOJ-UHFFFAOYSA-N |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 518654 | Sigma-Aldrich | 4-Amino-2-chloro-6,7-dimethoxyquinazoline | 95% | 880.76元/25 G; | 咨询 |
基本信息 | 经验(实验)分子式 | C10H10ClN3O2 | | 分子量 | 239.66 | | Beilstein | 747463 | | EC 号 | 245-821-7 | | MDL编号 | MFCD00051734 | | PubChem化学物质编号 | 24874035 | | NACRES | NA.22 |
产品性质 | 质量水平 | 100 | | 测定 | 95% | | mp | 262-268 ℃ (dec.) (lit.) | | SMILES string | COc1cc2nc(Cl)nc(N)c2cc1OC | | InChI | 1S/C10H10ClN3O2/c1-15-7-3-5-6(4-8(7)16-2)13-10(11)14-9(5)12/h3-4H,1-2H3,(H2,12,13,14) | | InChI key | HWIIAAVGRHKSOJ-UHFFFAOYSA-N |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| Y0002095 | | Prazosin impurity A | European Pharmacopoeia (EP) Reference Standard | 1259.15元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 0.002 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C10H10ClN3O2 | | 分子量 | 239.66 | | Beilstein | 747463 | | MDL编号 | MFCD00051734 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | mp | 262-268 ℃ (dec.) (lit.) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | COc1cc2nc(Cl)nc(N)c2cc1OC | | InChI | 1S/C10H10ClN3O2/c1-15-7-3-5-6(4-8(7)16-2)13-10(11)14-9(5)12/h3-4H,1-2H3,(H2,12,13,14) | | InChI key | HWIIAAVGRHKSOJ-UHFFFAOYSA-N |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P261 - P280 - P280 - P302 + P352 - P304 + P340 + P312 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHR3308 | Supelco | Doxazosin Related Compound C | certified reference material, pharmaceutical secondary standard | 5550.11元/50 mg; | 咨询 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA6959(changes by product) in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C10H10ClN3O2 | | 分子量 | 239.66 | | Beilstein | 747463 | | MDL编号 | MFCD00051734 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | 包装 | pkg of 50 mg | | mp | 262-268 ℃ (dec.) (lit.) | | application(s) | pharmaceutical | | 药典可追溯性 | traceable to USP 1225452 | | SMILES string | COc1cc2nc(Cl)nc(N)c2cc1OC | | InChI | 1S/C10H10ClN3O2/c1-15-7-3-5-6(4-8(7)16-2)13-10(11)14-9(5)12/h3-4H,1-2H3,(H2,12,13,14) | | InChI key | HWIIAAVGRHKSOJ-UHFFFAOYSA-N |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1225452 | USP | Doxazosin Related Compound C | United States Pharmacopeia (USP) Reference Standard | 11011.4元/20 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C10H10ClN3O2 | | 分子量 | 239.66 | | Beilstein | 747463 | | MDL编号 | MFCD00051734 | | PubChem化学物质编号 | 329749671 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | mp | 262-268 ℃ (dec.) (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | COc1cc2nc(Cl)nc(N)c2cc1OC | | InChI | 1S/C10H10ClN3O2/c1-15-7-3-5-6(4-8(7)16-2)13-10(11)14-9(5)12/h3-4H,1-2H3,(H2,12,13,14) | | InChI key | HWIIAAVGRHKSOJ-UHFFFAOYSA-N |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 024926 | Fluorochem | 4-Amino-2-chloro-6,7-dimethoxyquinazoline | 98% | 220元/10g; 220元/1g; 396元/25g; | 咨询 |
基本信息 | CAS Number | 23680-84-4 | | MDL Number | MFCD00051734 |
安全信息 | 图形或危害标志 |  | | 危险性说明 | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H332: Harmful if inhaled. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing . P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.. P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see relevant procedures. on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to in accordance with local regulation .
|
|
| HY-W087019 | MCE | ACDQ,23680-84-4_MCE(MedChemExpress) | | 100元/5 g; 140元/10 g; 240元/25 g; | 咨询 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 MCE 国际站:ACDQ 品牌:MedChemExpress (MCE) 货号:HY-W087019 CAS 号:23680-84-4 生物活性: ACDQ(4-氨基-2-氯-6,7-二甲氧基喹唑啉)是一种可用于合成喹唑啉类抗菌剂的药物中间体。ACDQ的分子对接结果表明其具有潜在的乙酰胆碱酯酶抑制活性,可应用于阿尔茨海默病相关研究[1][2]。 体外研究(In Vitro):Others Others ACDQ (4-Amino-2-chloro-6,7-dimethoxyquinazoline) 可在 120 °C 条件下与哌啶胺中间体反应 12 h,成功偶联生成喹唑啉类抗菌剂[1]。ACDQ (4-Amino-2-chloro-6,7-dimethoxyquinazoline) 的分子对接结果显示,可与重组人乙酰胆碱酯酶 (4EY7) 的结合能力最强,结合能为 -8.1 kcal mol−1,并与四种与阿尔茨海默病相关的不同乙酰胆碱酯酶蛋白形成稳定的氢键和非共价相互作用[2]。 MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. 仅供参考。 分子量:239.66 Formula:C10H10ClN3O2 性状:固体 颜色:White to off-white 运输条件:美国大陆地区的室温;其他地区可能有所不同。 储存方式:4°C,避光保存 *溶剂保存:-80°C,6个月;-20°C,1个月(避光保存) 提供质量检测报告:Data Sheet、SDS、COA、HNMR、产品使用指南 产品活性:ACDQ (4-Amino-2-chloro-6,7-dimethoxyquinazoline) 是一种药物中间体,可用于合成喹唑啉类抗菌剂。ACDQ 的分子对接结果显示其具有潜在乙酰胆碱酯酶抑制剂活性,可用于阿尔茨海默病相关研究。 相关产品:Sodium formate | 7-Deaza-2'-deoxy-7-iodoadenosine | 2′-O-(2-Methoxyethyl)adenosine | 8-Azahypoxanthine | DMT-2'O-Methyl-rU Phosphoramidite | 8-Bromoadenine | 2'-O-MOE-5-Me-rU | 7-Deaza-2'-deoxyadenosine | 5'-O-DMT-N4-Ac-dC | 2'-O-MOE-5-Me-rC | β-Thujaplicinol | L-Tyrosyl-L-glutamic acid 热门产品线:抑制剂 | 稳定性同位素标记物 | 脂质 | 糖类 Trending products:Inhibitors | Isotope-Labeled Compounds | Lipids | Saccharides MCE 抑制剂: MedChemExpress (MCE) 提供抑制剂、激动剂、拮抗剂、激活剂、调节剂、降解剂、配体和底物等多种生物活性化合物,可用于靶点功能验证、信号转导机制研究、细胞表型分析、疾病机制研究、药效评价及活性化合物筛选。 MedChemExpress 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶/受体酪氨酸激酶、干细胞/Wnt、TGF-β/Smad 及维生素 D/核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,助力客户发表文献超 80,000 篇。 相关产品可根据具体情况提供化学结构、作用靶点、生物活性、纯度、溶解度、体内外研究信息、参考文献及质量分析报告 (COA)等资料。 客户发表文献: [1]. Nature. 2026 Sep;657(8131):549-558. [2]. Nature. 2026 Sep;657(8132):755-764. [3]. Nature. 2026 Sep;657(8133):1027-1034. [4]. Nature. 2026 Sep;657(8131):477-486. [5].Nature. 2026 Sep;657(8132):789-799. [6]. Nature. 2026 Sep;657(8131):517-524. [7]. Nature. 2026 Sep;657(8133):1045-1052. [8]. Cell. 2026 Sep 14:S0092-8674(26)01003-2. [9]. Cell. 2026 Sep 3;189(18):5688-5705.e13. [10]. Cell. 2026 Sep 2:S0092-8674(26)00937-2. 参考文献: [1]. Kung PP, et al. Structure-activity relationships of novel 2-substituted quinazoline antibacterial agents. Journal of medicinal chemistry. 1999 Nov 04;42(22):4705-13. [2]. Asokan K, et al. Combined Experimental and Computational Investigations of 4‑Amino‑2‑Chloro‑6,7‑Dimethoxyquinazoline as Potential Anti‑Alzheimer Agent. International Journal of Quantum Chemistry, 2024, 124(24): e27527. 品牌介绍: MedChemExpress (MCE) 是全球领先的生命科学试剂供应商,致力于为生命科学研究与药物发现提供创新解决方案。我们提供包括抑制剂、化合物库、重组蛋白、抗体、多肽和一站式AI药物筛选等在内的全品类、高品质活性分子和技术服务,品质卓越,是科研领域值得信赖的合作伙伴。MCE 总部位于美国新泽西州,并在全球范围内建立了多个研发、生产和物流中心。 全面的产品矩阵: MedChemExpress 拥有超过 200,000 种以上的生物活性分子,覆盖广泛的信号通路与研究领域,包括靶点与疾病机制研究;检测、分析与质控;疾病建模与药物筛选;干细胞研究与细胞治疗;基因治疗以及其他药物发现领域。 ● 靶点与疾病机制研究:抑制剂与激动剂、PROTAC、ADC、重组蛋白、抗体抑制剂、多肽、诱导疾病模型产品、动物饲料产品 ● 检测、分析与质控:同位素标记化合物、荧光染料、参考标准品、抗体、酶、试剂盒 ● 干细胞研究与细胞治疗:GMP 小分子、类器官相关蛋白、Matrigel、培养基、血清 ● 基因治疗:小RNA、脂质体、佐剂、限制性内切酶、PCR、qPCR 试剂盒
一站式 AI 药物筛选平台 一站式AI药物筛选平台提供超过 200 种筛选库及多种化合物和表型筛选服务。这些服务包括 DNA 编码化合物库筛选、虚拟筛选、高通量筛选(HTS)、离子通道检测、激酶筛选与谱系分析、表型筛选、亲和质谱筛选、定制化合物合成、结构优化与分析服务等。我们致力于不断提升平台能力,通过打造一站式药物发现服务,推动科学研究,释放创新的无限潜力。
行业领先的生物信息学 • 靶点与信号通路:JAK、STAT、PD-1/PD-L1、KRAS、STING、铁死亡等; • 权威支持:来自权威文献的体内/体外实验方案; • 动态数据:超过 15 万条溶解度真实测试、数千万条基因信息、临床/批准跟踪数据; • MedChemExpress 广泛应用:药理学与生物学研究,覆盖 400 余种疾病/领域研究,包括癌症、神经疾病、炎症、代谢、干细胞等;产品已为全球 13,000 家研究机构所用,相关成果累计获 Nature、Cell、Science 等权威期刊引用超 85,000 次。 • 7×24 专业服务:已服务客户百万次;前订单确保当日发货。
严格的多重质量控制 • 国际标准:严格遵循 ISO 9001:2015、ISO 9001、ISO 17025、ICH Q7 等质量与环境管理体系; • 完整平台:400 多台精密仪器,1000 名研发与分析人员; • 全面检测:NMR、HPLC、LC-MS、IR、元素分析等; • MedChemExpress 生物验证平台:四大平台(分子/蛋白/细胞/体内实验)支持药效评估; • MCE 中国官网:www.MedChemExpress.cn
全球业务与仓储中心 全球仓储中心覆盖北美、中国、欧洲、日本等地区,拥有数十个仓库,90% 区域实现次日达,能够快速响应全球客户需求。
Hotline: 400-820-3792 Tel: 021-58955995 Email: sales@MedChemExpress.cn Tech Support: 021-58950656
|